These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
70 related items for PubMed ID: 1490434
1. Sulodexide oral administration influences blood viscosity and fibrinolysis. Crepaldi G, Rossi A, Coscetti G, Abbruzzese E, Calveri U, Calabrò A. Drugs Exp Clin Res; 1992; 18(5):189-95. PubMed ID: 1490434 [Abstract] [Full Text] [Related]
2. Effects of gemfibrozil and ciprofibrate on plasma levels of tissue-type plasminogen activator, plasminogen activator inhibitor-1 and fibrinogen in hyperlipidaemic patients. Kockx M, de Maat MP, Knipscheer HC, Kastelein JJ, Kluft C, Princen HM, Kooistra T. Thromb Haemost; 1997 Oct; 78(4):1167-72. PubMed ID: 9364979 [Abstract] [Full Text] [Related]
3. Age dependence of blood fibrinolytic components and the effects of low-dose oral contraceptives on coagulation and fibrinolysis in teenagers. Siegbahn A, Ruusuvaara L. Thromb Haemost; 1988 Dec 22; 60(3):361-4. PubMed ID: 3149043 [Abstract] [Full Text] [Related]
4. [Effects on the coagulation-fibrinolysis system of a single oral dose of mesoglycan at the beginning and at the end of a prolonged treatment in man]. Blardi P, Messa G, Puccetti L, La Placa G, Ghezzi A. Recenti Prog Med; 1995 Dec 22; 86(7-8):282-9. PubMed ID: 7569284 [Abstract] [Full Text] [Related]
9. [Hemocoagulation and hemorheology in heart failure and the possible effects of glycosaminoglycans]. Spinar J, Novotný J, Mayer J, Vítovec J, Spinarová L. Vnitr Lek; 1995 Jan 22; 41(1):3-7. PubMed ID: 7716890 [Abstract] [Full Text] [Related]
11. Plasminogen activator inhibitor type-1 determines plasmin formation in patients with ischaemic heart disease. Pedersen OD, Gram J, Jespersen J. Thromb Haemost; 1995 May 22; 73(5):835-40. PubMed ID: 7482412 [Abstract] [Full Text] [Related]
12. The effect of glycosaminoglycan sulodexide on oxidative stress and fibrinolysis in diabetes mellitus. Skrha J, Perusicová J, Kvasnicka J, Hilgertová J. Sb Lek; 1998 May 22; 99(2):103-9. PubMed ID: 10536489 [Abstract] [Full Text] [Related]
14. Changes in the fibrinolytic components of cultured human umbilical vein endothelial cells induced by endotoxin, tumor necrosis factor-alpha and interleukin-1alpha. Orbe J, Chordá C, Montes R, Páramo JA. Haematologica; 1999 Apr 22; 84(4):306-11. PubMed ID: 10190943 [Abstract] [Full Text] [Related]
15. Increased fibrinolytic activity during use of oral contraceptives is counteracted by an enhanced factor XI-independent down regulation of fibrinolysis: a randomized cross-over study of two low-dose oral contraceptives. Meijers JC, Middeldorp S, Tekelenburg W, van den Ende AE, Tans G, Prins MH, Rosing J, Büller HR, Bouma BN. Thromb Haemost; 2000 Jul 22; 84(1):9-14. PubMed ID: 10928462 [Abstract] [Full Text] [Related]
17. Levels of fibrinolytic activators and inhibitors in plasma after severe trauma. Sørensen JV. Blood Coagul Fibrinolysis; 1994 Feb 22; 5(1):43-9. PubMed ID: 7514044 [Abstract] [Full Text] [Related]
18. Effect of amlodipine-atorvastatin combination on fibrinolysis in hypertensive hypercholesterolemic patients with insulin resistance. Fogari R, Derosa G, Lazzari P, Zoppi A, Fogari E, Rinaldi A, Mugellini A. Am J Hypertens; 2004 Sep 22; 17(9):823-7. PubMed ID: 15363826 [Abstract] [Full Text] [Related]